Teplizumab approval for type 1 diabetes in the USA.

Beran D., Abidha C., Adler A., de Beaufort C., Lepeska M., Levitt N., Pfiester E., Zafra-Tanaka JH., Gale EA.

DOI

10.1016/S2213-8587(22)00384-9

Type

Journal article

Publication Date

2023-02-01T00:00:00+00:00

Volume

11

Pages

78 - 80

Total pages

2

Keywords

Humans, Antibodies, Monoclonal, Humanized, Diabetes Mellitus, Type 1, Hypoglycemic Agents

Permalink More information Close